News Lumen News Press ReleaseLumen in the NewsScientific PublicationsCorporate Blog & Bylines Lumen Press Releases View More 9/22/2020 Lumen Bioscience Awarded Federal Grant to Rapidly Develop Antibody-based Covid-19 Therapeutic 9/1/2020 Lumen Bioscience Raises $16M Series B Financing to Accelerate Clinical Development of Accessible Biologic Drugs 7/23/2020 Lumen Wins Triple Funding Boost to Advance Development of Low-Cost Therapeutics for Newborns and Infants in Developing Countries 7/23/2020 Dr. Craig Behnke Joins Lumen Bioscience as SVP, Production and Development 7/23/2020 Lumen Bioscience Announces Issuance of US Patent for Genetic Modification of Spirulina 7/8/2020 NIH Awards Grant to Lumen Bioscience for Cost-Effective Oral Malaria Vaccine Pagination First page « Pagination_arrow Previous page ‹ Page 1 Page 2 Page 3 Current page 4 Page 5 Pagination_arrow Next page › Last page » Lumen in the News View More BARDA and Lumen Bioscience partner on a rapidly scalable novel manufacturing platform to develop an intranasal antibody cocktail to treat COVID-19 April 27th, 2022 When Free Markets Fail... and Maybe You Die April 25th, 2022 Trial Set for Gut Infection Biologic Treatment April 18th, 2022 Pagination First page « Pagination_arrow Previous page ‹ Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Pagination_arrow Next page › Last page » Scientific Publications View More No scientific publications are available at this time. Check back soon. Pagination First page « Pagination_arrow Previous page ‹ Page 1 Current page 2 Corporate Blog & Bylines View More COVID drugs come in 3 flavors; it’s time for more diversity October 12th, 2021 Covid therapies must look beyond the lungs October 6th, 2021 Unlocking Biologic Drug Production September 22, 2021 Podcast Pagination First page « Pagination_arrow Previous page ‹ Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Pagination_arrow Next page › Last page »
